| 专利名称 | CACNA1H-DERIVED TUMOR ANTIGEN POLYPEPTIDE AND USE THEREOF | ||
| 申请号 | US16338126 | 申请日 | |
| 公开(公告)号 | US20200024316A1 | 公开(公告)日 | |
| 申请(专利权)人 | Genoimmune Therapeutics Co Ltd | 发明人 | Guanglei LI; Yong HOU; Shuntao LUO; Xiumei LIN; Ting AN; Bo LI; Wei ZHANG; Chengchi CHAO; Zhen CHENG; Handong LI; Naibo YANG |
| 专利来源 | 国家知识产权局 | 转化方式 | |
| 摘要 |
Provided are a tumor antigen polypeptide having the amino acid sequence as shown in SEQ ID NO : 2 or a variant thereof; a nucleic acid encoding the same; a nucleic acid construct, an expression vector, and a host cell containing the encoding nucleic acid; and an antigen presenting cell presenting the tumor antigen polypeptide on the cell surface and an immune effector cell thereof. Also provided is the use of the polypeptide, nucleic acid, antigen presenting cell or immune effector cell in the diagnosis, prevention and treatment of cancers. |
||
主管部门:海南中小企业服务 | 建设单位:海南商业联合会
版权所有:海南商业联合会 | 备案号:粤ICP备13083911号(ICP加挂服务)@2017